North America Clinical Chemistry Analyzers Market Size, Share & Industry Trends Analysis Report By End User, By Test Type, By Product (Reagents, Analyzers, and Others), By Country and Growth Forecast, 2023 - 2030

North America Clinical Chemistry Analyzers Market Size, Share & Industry Trends Analysis Report By End User, By Test Type, By Product (Reagents, Analyzers, and Others), By Country and Growth Forecast, 2023 - 2030


The North America Clinical Chemistry Analyzers Market would witness market growth of 3.9% CAGR during the forecast period (2023-2030).

An important aspect contributing to the market's expansion is the introduction of novel items. The combined immunochemistry and clinical chemistry analyzers permit immunoassay-based testing, which significantly broadens the range of tests that can be carried out on a single system and cuts down on the time needed for quality inspections and maintenance of these analyzers. The integrated analyzers are available in various sample workloads and quantities (low, medium, and high) to meet the needs of the hospital and reference laboratories, which also helps to fuel demand and market expansion.

Clinical chemistry analyzers' technological advancements have made it possible to test more people and have enabled the early diagnosis of disease as well as specialized diagnoses in the fields of oncology, gynecology, and endocrinology. Advanced modeling and parameter estimates, greater resolution, better pattern recognition, artificial intelligence, and computer-assisted interpretation are some of the developments.

The rising demand for early diagnoses is further propelling the market's expansion in the North American region. For instance, the Canadian Cancer Society's 2021 study estimates that there were roughly 229,200 new instances of cancer identified in Canada that year. Additionally, 628 Canadians are receiving cancer diagnoses daily on average, with future projections indicating an increase in this number. The most common cancers in Canada (aside from non-melanoma skin cancer), according to the same survey, are breast, colorectal, lung, and prostate cancer. New, cutting-edge items are being introduced to the market by the leading manufacturers. Therefore, the market will expand rapidly in North America due to all the aforementioned factors.

The US market dominated the North America Clinical Chemistry Analyzers Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $3,953.3 million by 2030. The Canada market is experiencing a CAGR of 6.3% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 5.4% during (2023 - 2030).

Based on End User, the market is segmented into Hospitals & Clinics, Diagnostic Laboratories, Research Laboratories & Institutes, and Others. Based on Test Type, the market is segmented into Basic Metabolic Panel, Renal Profile, Liver Panel, Lipid Profile, Thyroid Function Panel, Electrolyte Panel, and Specialty Chemical Tests. Based on Product, the market is segmented into Reagents, Analyzers, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include F. Hoffmann-La Roche Ltd., Danaher Corporation, Abbott Laboratories, Thermo Fisher Scientific, Inc., Siemens Healthineers AG (Siemens AG), Horiba Ltd., Sysmex Corporation, Hitachi, Ltd., EKF Diagnostics Holdings plc and Ortho-Clinical Diagnostics, Inc. (QuidelOrtho Corporation).

Scope of the Study

Market Segments covered in the Report:

By End User
  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Research Laboratories & Institutes
  • Others
By Test Type
  • Basic Metabolic Panel
  • Renal Profile
  • Liver Panel
  • Lipid Profile
  • Thyroid Function Panel
  • Electrolyte Panel
  • Specialty Chemical Tests
By Product
  • Reagents
  • Analyzers
  • Others
By Country
  • US
  • Canada
  • Mexico
  • Rest of North America
Companies Profiled
  • F. Hoffmann-La Roche Ltd.
  • Danaher Corporation
  • Abbott Laboratories
  • Thermo Fisher Scientific, Inc.
  • Siemens Healthineers AG (Siemens AG)
  • Horiba Ltd.
  • Sysmex Corporation
  • Hitachi, Ltd.
  • EKF Diagnostics Holdings plc
  • Ortho-Clinical Diagnostics, Inc. (QuidelOrtho Corporation)
Unique Offerings from KBV Research
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Clinical Chemistry Analyzers Market, by End User
1.4.2 North America Clinical Chemistry Analyzers Market, by Test Type
1.4.3 North America Clinical Chemistry Analyzers Market, by Product
1.4.4 North America Clinical Chemistry Analyzers Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter’s Five Forces Analysis
Chapter 4. North America Clinical Chemistry Analyzers Market by End User
4.1 North America Hospitals & Clinics Market by Country
4.2 North America Diagnostic Laboratories Market by Country
4.3 North America Research Laboratories & Institutes Market by Country
4.4 North America Others Market by Country
Chapter 5. North America Clinical Chemistry Analyzers Market by Test Type
5.1 North America Basic Metabolic Panel Market by Country
5.2 North America Renal Profile Market by Country
5.3 North America Liver Panel Market by Country
5.4 North America Lipid Profile Market by Country
5.5 North America Thyroid Function Panel Market by Country
5.6 North America Electrolyte Panel Market by Country
5.7 North America Specialty Chemical Tests Market by Country
Chapter 6. North America Clinical Chemistry Analyzers Market by Product
6.1 North America Reagents Market by Country
6.2 North America Analyzers Market by Country
6.3 North America Others Market by Country
Chapter 7. North America Clinical Chemistry Analyzers Market by Country
7.1 US Clinical Chemistry Analyzers Market
7.1.1 US Clinical Chemistry Analyzers Market by End User
7.1.2 US Clinical Chemistry Analyzers Market by Test Type
7.1.3 US Clinical Chemistry Analyzers Market by Product
7.2 Canada Clinical Chemistry Analyzers Market
7.2.1 Canada Clinical Chemistry Analyzers Market by End User
7.2.2 Canada Clinical Chemistry Analyzers Market by Test Type
7.2.3 Canada Clinical Chemistry Analyzers Market by Product
7.3 Mexico Clinical Chemistry Analyzers Market
7.3.1 Mexico Clinical Chemistry Analyzers Market by End User
7.3.2 Mexico Clinical Chemistry Analyzers Market by Test Type
7.3.3 Mexico Clinical Chemistry Analyzers Market by Product
7.4 Rest of North America Clinical Chemistry Analyzers Market
7.4.1 Rest of North America Clinical Chemistry Analyzers Market by End User
7.4.2 Rest of North America Clinical Chemistry Analyzers Market by Test Type
7.4.3 Rest of North America Clinical Chemistry Analyzers Market by Product
Chapter 8. Company Profiles
8.1 F. Hoffmann-La Roche Ltd.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Product Launches and Product Expansions:
8.1.6 SWOT Analysis
8.2 Danaher Corporation
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 SWOT Analysis
8.3 Abbott Laboratories
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.4 Thermo Fisher Scientific, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.4.6 SWOT Analysis
8.5 Siemens Healthineers AG (Siemens AG)
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 SWOT Analysis
8.6 Horiba Ltd.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional & Segmental Analysis
8.6.4 Research & Development Expenses
8.6.5 Recent strategies and developments:
8.6.5.1 Trials and Approvals:
8.6.5.2 Acquisition and Mergers:
8.6.6 SWOT Analysis
8.7 Sysmex Corporation
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.7.5.2 Product Launches and Product Expansions:
8.7.6 SWOT Analysis
8.8 Hitachi, Ltd.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expenses
8.8.5 SWOT Analysis
8.9 EKF Diagnostics Holdings plc
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expenses
8.9.5 SWOT Analysis
8.10. Ortho-Clinical Diagnostics, Inc. (QuidelOrtho Corporation)
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 Research & Development Expense
8.10.5 SWOT Analysis

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings